Next Article in Journal
Monomers and Macromolecular Materials from Renewable Resources: State of the Art and Perspectives
Previous Article in Journal
Efficient Extraction of Fermentation Inhibitors by Means of Green Hydrophobic Deep Eutectic Solvents
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 1
10.3390/molecules27010158
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione

by
Joanna Płonka
1,
Joanna Szablińska-Piernik
2,
Bogusław Buszewski
3,4,
Irena Baranowska
1 and
Lesław B. Lahuta
2,*
1
Department of Inorganic Chemistry, Analytical Chemistry and Electrochemistry, Faculty of Chemistry, Silesian University of Technology, B. Krzywoustego 6, 44-100 Gliwice, Poland
2
Department of Plant Physiology, Genetics and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A/103A, 10-719 Olsztyn, Poland
3
Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University, Gagarina 7, 87-100 Toruń, Poland
4
Interdisciplinary Centre of Modern Technologies, Nicolaus Copernicus University, Wileńska 4, 87-100 Toruń, Poland
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(1), 158; https://doi.org/10.3390/molecules27010158
Submission received: 7 December 2021 / Revised: 23 December 2021 / Accepted: 26 December 2021 / Published: 28 December 2021
(This article belongs to the Section Analytical Chemistry)
Browse Figures
Versions Notes

Abstract

:
The conditions for determining the antioxidant properties of cyclitols (d-pinitol, l-quebrachitol, myo-, l-chiro-, and d-chiro-inositol), selected flavanones (hesperetin, naringenin, eriodictyol, and liquiritigenin) and glutathione by spectrophotometric methods—CUPRAC and with DPPH radical, and by a chromatographic method DPPH-UHPLC-UV, have been identified. Interactions of the tested compounds and their impact on the ox-red properties were investigated. The RSA (%) of the compounds tested was determined. Very low antioxidative properties of cyclitols, compared with flavanones and glutathione alone, were revealed. However, a significant increase in the determined antioxidative properties of glutathione by methyl-ether derivatives of cyclitols (d-pinitol and l-quebrachitol) was demonstrated for the first time. Thus, cyclitols seem to be a good candidate for creating drugs for the treatment of many diseases associated with reactive oxygen species (ROS) generation.

1. Introduction

In recent years, there has been a growing interest in inositols (cyclic six-carbon polyalcohols), including myo-inositol, present in all living organisms [1], and in their isomers (d-chiro-inositol, scyllo-inositol) and methyl derivatives (d-pinitol, l-quebrachitol), found in various wild and medicinal plants and crops [2,3,4].
Myo-Inositol, synthesized from glucose in three enzymatic steps, serves as a substrate for the synthesis of phosphatidylinositol, a major compound of cellular membranes, inositol high-energy pyrophosphates (implicated in phosphate and energy-sensing) and inositol phosphates (signaling molecules), including phytic acid (inositol hexakisphosphate) playing an important role in the storage/release of metal ions, as well as phosphate residues [5,6]. Moreover, myo-inositol in plants participates in the auxin transport/signaling, synthesis of cell wall compounds (hemicelluloses and pectin), and synthesis of galactinol and raffinose family oligosaccharides, compatible sugars [7,8]. Myo-Inositol and its isomers or methylated ethers (abundant in plants) are transported from source to sink tissues [9] and are accumulated to relatively high concentration under abiotic stresses, like drought or salinity, by participating in osmotic regulation and protecting the structure of macromolecules [10,11].
In humans, myo-inositol plays an important role in the processes of cell regulation, signal transduction, osmoregulation, and ion channel physiology, and is a component of the cell membrane [12]. Myo-inositol is involved in increasing the insulin sensitivity of various tissues. Together with d-chiro-inositol (a product of myo-inositol epimerization), regulates cellular glucose uptake and promotes glycogen synthesis [13]. Inositol deficiency may be involved in the pathogenesis of diseases, such as metabolic syndrome, spina bifida (a neural tube defect), polycystic ovary syndrome (PCOS), and diabetes [14,15]. Supplementation of the two inositol stereoisomers, d-chiro-inositol and myo-inositol is important to prevent these conditions [15]. Both are studied as metabolites with pro-health [12] and therapeutic properties, due to their insulin-sensitizing, anti-atherogenic, anti-inflammatory, anti-oxidative, and anti-cancer properties [12,14]. They are successfully applied in the treatment of PCOS and non-insulin-dependent diabetes mellitus [16,17]. The treatment with myo-inositol assists in the prevention of dyslipidemia, while combined therapy of myo-inositol and d-chiro-inositol improves the metabolic profile of obese PCOS patients, reducing the risk of cardiovascular disease [14]. The use of myo-inositol seems to be efficient for the treatment of depression, anxiety, and compulsive disorders [18,19]. Moreover, d-pinitol, indicating multifunctional properties (anti-diabetic, anti-cancer, hepatoprotective, antioxidant, anti-aging, and immunosuppressive), seems to be a good candidate for the treatment of various diseases [20,21,22]. Another methylated inositol—l-quebrachitol, chemically like d-pinitol (Figure S1), indicates gastroprotection, anti-platelet aggregation, anti-diabetic activity, and free-radical scavenging properties [23], and promotes osteoblastogenesis, while d-pinitol possesses inhibitory activity against osteoclastogenesis [24]. Thus, both cyclitols can be used in the treatment of osteoporosis. Although various mechanisms of cyclitols activity in the prevention/treatment of diseases are proposed [20,21,25], little is known about their antioxidant properties.
Some reports suggest that cyclitols act directly as scavengers of hydroxyl radicals [26] or indirectly, via enhancing antioxidative enzymes [22]. Such properties create an opportunity to use plant-derived cyclitols (mainly d-chiro-inositol and d-pinitol) in the treatment of some metabolic disorders, or plant food rich in cyclitols as a dietary supplement in the prevention of diseases [20,21,22]. However, analyses of the antioxidant properties of cyclitols with typical stable radicals, like DPPH (2,2-diphenyl-1-picrylhydrazyl), are rare [27]. Moreover, some reports indicate weak antioxidant activity of inositols [28] and their derivatives [29]. Thus, analyses of the antioxidant properties of the most important cyclitols (myo-inositol, d-pinitol, d-chiro-inositol, l-quebrachitol; Figure S1) seem important. Additionally, it could be hypothesized that cyclitols produce a synergistic effect with other antioxidants, like flavonoids [30], naturally occurring in plants and plant-derived food [31], or glutathione, an important antioxidant in both plants [32,33] and animals [34].
In plant tissues, apart from cyclitols, there are other compounds with antioxidant properties, for example, ascorbic acid (Vit C), glutathione, tocopherol (Vit E), carotenoids, anthocyanins, and various phenolic compounds, including polyphenols [35,36,37]. Among them, there are flavonoids with documented medicinal properties related to the regulation of ox-red processes in cells, including the maintenance of redox balance, disturbed by oxidative stress [38]. Disturbances in this balance are most often associated with the overproduction of reactive oxygen species (ROS). Oxidative stress damages the DNA and lipids change the structures and functions of proteins and carbohydrates and lower the concentration of intracellular ATP [38]. Many cardiovascular diseases are caused by oxidative modifications that disturb cellular homeostasis [39]. The multidirectional action of flavonoids is also manifested in their estrogenic, anti-inflammatory, antidiabetic, and cytostatic properties [40]. Oxidative stress plays a significant role in neurological diseases [41], including depression and neurodegenerative diseases [42,43]. Flavonoids are used as antidepressants, and their increasing use in medicine gives hope for the treatment of the so-called civilization diseases. Flavanones, which contain a stereogenic center and can therefore exist in the form of various enantiomers, are the least studied flavonoids in terms of antioxidant properties [44,45,46]. The flavanones that are the subject of this research include hesperetin, naringenin, eriodictyol, and liquiritigenin [47,48,49]. The spatial structure is significantly related to the possibility of fitting into an organism’s protein structures, for example, an enzyme. This is especially significant in the case of drugs because one of the isomers may have therapeutic properties while the other may be inactive or even have a negative effect (e.g., thalidomide, the S-enantiomer of which has proved to be teratogenic [50]).
Glutathione is an endogenous antioxidant that plays an important role in the functioning of living organisms. It is a tripeptide (γ-glutamyl-cysteinyl-glycine), a small intracellular thiol molecule considered to be a strong non-enzymatic antioxidant [32]. Its antioxidant properties rely on the restoration of thiol groups—SH in proteins that have been oxidized to disulfide -S-S- or sulfonic groups—SO3H. Owing to the free thiol group, GSH has the ability to reduce peroxides. It is also a coenzyme of some ox-red enzymes. Reduced glutathione (GSH) reacts with active oxygen species and thus protects protein thiol groups against irreversible inactivation [51]. Pereira et al. [52] noted the possibility of synergistic or antagonistic interactions between endogenous GSH antioxidant and exogenous antioxidants, for example, with some flavonoids. It has been pointed out that the presence of a catechol group in the B-ring of flavonoids is an essential condition for the synergism with GSH. The described studies were carried out in vitro, and it is expected that in in-vivo conditions the influence on the course of interactions will be additionally dependent on the bioavailability and biotransformation of the tested compounds, also in the presence of other metabolites, for example, cyclitols. In the present work, we show the results of our analyses of the antioxidant properties of selected cyclitols and their influence on the antioxidant properties of flavanones and glutathione.

2. Results and Discussion

2.1. Studies of Antioxidant Properties of Cyclitols by Spectrophotometric Methods

Due to the lack of data on the ox-red properties of cyclitols in the scientific literature, with the use of methods usually employed for this purpose, that is, the CUPRAC method or with the DPPH radical, systematic tests were carried out using both of these methods. In the preliminary study, using cyclitols at concentrations typical for an assay of antioxidative activity (in the order of μg/mL), any antioxidant activity of the tested cyclitols was detectable. Therefore, tests were carried out with the use of solutions with concentrations 1000-fold higher (in the order of mg/mL).
In the CUPRAC method, a very weak interaction of d-pinitols (standard and obtained from carob), l-quebrachitol, and myo-inositol with Cu(II) ions was observed, and practically no reaction of the other inositols was tested. Tests were also carried out with the addition of known antioxidants, that is, flavanones, from the group of flavonoids (hesperetin, naringenin, eriodictyol, and liquiritigenin), at a concentration of μg/mL. The tested flavanones turned out to be strong antioxidants in the CUPRAC method, and d-pinitol (both standard and carob-derived) and myo-inositol added to the mixture of flavanones had only a slight effect on the ox-red properties of flavanones, causing little synergism or antagonism of action (Figure 1). The presented synergistic effect of d-pinitol from carob on the ox-red properties of flavanones can only be noticed at a high concentration of d-pinitol (in the order of mg/mL), at the concentration of flavanones from 5–15 µg/mL. Figure 2 shows the effects of l-quebrachitol and myo-inositol on the antioxidant properties of flavanones. Taking into account the very high concentrations of the cyclitols used, it should be assumed that their independent effect on the reduction of copper ions in in vivo conditions is unlikely.
In the DPPH radical method, where the reaction is carried out in an alcoholic environment, only d-pinitol and l-quebrachitol were tested, as the remaining cyclitols precipitated in the reaction medium. Obviously, it was necessary to use solutions with a concentration of mg/mL due to the very poor antioxidant properties of the tested compounds. During the reaction, weak ox-red properties of the tested compounds in relation to the DPPH radical are observed—a slight lowering of the absorbance of the DPPH solution (Figure 3). It should be expected that the impurities present in d-pinitol isolated from carob (ca 5% of myo-inositol, traces of d-chiro-inositol, and glycerol, Figure S2) may affect its ox-red properties.
Studies of the reaction of d-pinitol with DPPH in the presence of flavanones were also carried out. Weak synergism or antagonism of the effect of d-pinitol on the ox-red properties of the tested flavanones was observed (Figure 3).
The reactions of DPPH with cyclitols in the presence of glutathione were conducted to explain the ox-red properties of cyclitols used in the treatment of various diseases. Results of our research on the antioxidant properties of cyclitols (Figure 1, Figure 2 and Figure 3) did not explain their positive effect on the treatment of diseases caused by oxidative stress. There was a suspicion that some endogenous compounds, present in every organism, may affect the results of the therapy as a result of synergism with cyclitols. Thus, it seemed natural to test glutathione, both separately and in mixtures with cyclitols and flavanones in reactions with the DPPH radical.
The influence of glutathione on the reaction with the DPPH radical was investigated and the quantitative dependence of the absorbance of the DPPH˙ solution on the amount of glutathione in the concentration range from 3 to 65 µg/mL was found. The effect of d-pinitol at concentrations of 3.3–11.7 mg/mL on reducing the absorbance of the DPPH˙ solution in the presence of 3.3–13.3 µg/mL of glutathione was investigated (Figure 4). There is significant synergy between the action of d-pinitol and glutathione. A similar synergy was found between the action of l-quebrachitol and glutathione (Figure S2). The influence of cyclitols on the antioxidant properties of glutathione depends on the type and/or origin of cyclitol.
Studies of the effect of glutathione on the antioxidant properties of flavanones in the DPPH radical method, not previously described in the literature, were also conducted. The studies were carried out with hesperetin, naringenin, eriodictyol, and liquiritigenin.
Figure 5 shows the changes in absorbance of the DPPH solution in the presence of glutathione, flavanones, and mixtures of glutathione with individual flavanones.
The effect of glutathione on the ox-red properties of hesperetin and eriodictyol with the DPPH radical is practically negligible. Weak antagonism is observed for reactions with naringenin and liquiritigenin. The differences are due to the influence of the structure of the flavanones studied on the formation of adducts with glutathione. Adducts formed at OH- groups of the ring B in flavanone and glutathione seem to be more important for the antioxidant capacity than adducts formed at OH- groups of the A ring.
A study of the effect of glutathione on the antioxidant properties of some flavonoids was conducted by Pereira [52], but it involved completely different flavonoids than the flavanones studied in this work. No studies have been conducted with cyclitols, which were the primary focus of this work.

2.2. Ultrafast UHPLC-UV Chromatographic Method for the Determination of Antioxidant Activities of Studied Cyclitols and Their Mixtures with Glutathione and Flavanones

Due to the very difficult solubility of most of the tested cyclitols in the reaction solution with the DPPH radical, for some of them, it was impossible to perform an analysis using the spectrophotometric method. In the spectrophotometric method, especially in view of poor ox-red properties of cyclitols, high concentration solutions had to be used, which in some cases resulted in precipitation of compounds during the measurements and made the measurements impossible. The advantage of chromatographic methods is the possibility of working with solutions of very low concentrations, so the determination of the antioxidant properties of cyclitols, flavanones, glutathione, and their mixtures with the DPPH radical by the UHPLC-UV was carried out. The author of the present study [53] has previously developed a UHPLC-UV procedure to study the ox-red properties of selected flavonoids (other than the flavanones studied in this work) without the presence of cyclitols or glutathione.
In the developed chromatographic method, the DPPH radical peak is observed on the chromatogram, with a retention time of Tr = 2.15 min at λ = 517 nm. During the reaction with the DPPH radical of cyclitols, flavanones, glutathione, and their mixtures, the peak area of DPPH˙ is reduced because of its reduction to DPPH-H, and these changes are proportional to the ox-red properties of the studied compounds. The peak area of DPPH radicals would decrease (as a result of color change from purple to yellow) when they encountered an antioxidant. Figure 6 shows an example of a chromatogram obtained for different mixtures of the examined compounds by the DPPH-UHPLC-UV method.
The difference in the reduction of the DPPH peak area (PA) between the blank sample and the sample of cyclitol, flavanone, or glutathione was used to calculate the percentage radical scavenging activity (% RSA) from the following Equation (1).
%   RSA   = ( PA blank − PA sample ) PA blank ∗ 100
Determination of %RSA values is a quantitative description of ox-red properties of the examined compounds. The present study, completely novel because of the examined cyclitols as well as flavanones and glutathione, was also carried out for mixtures of the analyzed compounds. The %RSA values determined in the present study for cyclitols, flavanones, and glutathione are shown in Table 1. In addition, the theoretical sum of RSA (%) of the mixture of cyclitol and antioxidant (Theoretical RSA% column) was calculated and the RSA for the mixture of cyclitol with particular antioxidants was determined experimentally (Experimental RSA% column). The arrows indicate the changes in RSA values.
The results show that the RSA% values for cyclitols are low (despite the use of high concentrations of the tested compounds), compared to those obtained for flavanones and glutathione, which confirms the very weak antioxidant properties of these cyclitols. Glutathione was found to be one of the strongest antioxidants among the examined compounds. Among the flavanones, eriodictyol has the strongest antioxidant properties and naringenin—the weakest. It should be noted that the RSA% values determined experimentally for specific mixtures differ significantly from those calculated for the sum of individual analytes. In mixtures of glutathione with cyclitols, the experimental values were in five cases higher or significantly higher than the theoretical ones (with d-pinitol from carob, with d-chiro-inositol and l-chiro-inositol), and practically unchanged with d -pinitol standard as well as with l-quebrachitol. It should be noted that the concentration of glutathione in the mixtures was 1000-fold lower than that of cyclitols. These are certainly very interesting data, given the constant presence of glutathione in living organisms, which will significantly affect the antioxidant properties of cyclitols used in medicine. In the case of mixtures of cyclitols with flavanones, antagonism occurred for most of the tested compounds, which may indicate the necessity of limiting flavonoid-rich products in the diet of patients, similarly to the treatment with some drugs for high blood pressure.
The concentration required to inhibit 50% of the radical scavenging effect (IC50) is also determined in works on the antioxidant activity of compounds. The IC50 index was determined from the results of a series of concentrations tested. A lower IC50 value corresponds to a larger scavenging activity. The values for selected compounds are presented in Table 2. IC50 values are given in concentration units, for example, μg/mL or mg/mL. The values obtained allow mutual comparisons of the ox-red properties of different compounds on the condition that measurements are carried out under the same conditions.
The data acquired from the determination of RSA and IC50 show that cyclitols are very weak antioxidants, but the ox-red properties increase significantly in the presence of glutathione. This is definitely important for the use of cyclitols as drugs. These data help to explain their efficacy and clarify the important role of human-derived glutathione as an essential factor involved in the therapy with these drugs.

3. Materials and Methods

3.1. Chemicals and Reagents

Cyclitols (myo-inositol, d- and l-chiro-inositol, l-quebrachitol and d-pinitol), flavanones (hesperetin, naringenin, eriodictyol, liquiritigenin), glutathione, DPPH (2,2-diphenyl-1-picrylhydrazyl radical), sugars (sucrose, trehalose, and monosaccharides—glucose, fructose, galactose), sugar alcohols (mannitol, xylitol, and ribitol), 1-(trimethylsilyl)imidazole, O-metoxyamine hydrochloride, N-methyl-N-(trimethylsilyl) trifluoroacetamide and pyridine were purchased from Sigma—Aldrich (St. Louis, MO, USA), and copper(II) chloride was purchased from Acros Organic (New Jersey, USA). Methanol, acetonitrile and trifluoroacetic acid (TFA, Merck, Darmstadt, Germany) were all HPLC grade. Analytical grade methanol, ethanol, and di-chloromethane were purchased from POCH S.A. (Gliwice, Poland). Doubly distilled water obtained from a laboratory purification system (Millipore, Milford, MA, USA) was used throughout the experiments.

3.2. Isolation and Purification of d-pinitol from Carob (Ceratonia siliqua L.)

3.2.1. Extraction Procedure

d-Pinitol was isolated from carob molasses (Inkom AS, Istanbul, Turkey). For decolorizing and removal of major debris, 50 mL of molasses was dissolved in 100 mL of water and transferred to a Millipore vacuum filtration set packed with 200 mL of two-layer bed: 50 mL of silica gel (60 Å, 230–400 mesh, 40–63 μm particle size) and 150 mL upper layer of mixture (1:1, v/v) of activated charcoal (Sigma Aldrich, Saint Louis, MO, USA) and celite 545 (0.02–0.1 mm particle size, Merck). The double distilled water was used as the eluent. The colourless eluate (600 mL) was concentrated on a vacuum rotary evaporator (Heidolph, Hei-VAP Value, Schwabach, Germany) to 200 mL and subjected to fermentation with Saccharomyces cerevisiae Type II (1 g, Sigma Aldrich, Lot #BCBQ3003V) for the selective removal of interfering carbohydrates, according to [54], for 3–7 days (at 30 °C). The degradation of sugars was monitored daily, with GC-FID method [55]. Briefly, 1 mL of solution (taken into 1.5 mL Eppendorf tubes) was heated at 95 °C for 10 min and centrifuged at 14,000× g (at 4 °C for 20 min). A part of supernatant (400 μL) was purified on a micro spin filter (750 μL, 0.2 PVDF, Thermo Scientific, Waltham, MA, USA). The clear filtrate (10 μL) and 10 μL of xylitol (at 10 mg/mL, as an external standard) were transferred into a 2 mL glass chromatographic vial and concentrated in a speed vacuum evaporator to dryness. The dry residue was derivatized and analyzed by GC-FID at conditions described in the next section (Section 3.2.2). Sugars (sucrose, fructose, glucose, galactose, trehalose), mannitol, and cyclitols (myo-inositol, d-pinitol, and d-chiro-inositol) were identified by comparison of their retention times with those of original standards. The concentration of each soluble carbohydrate was calculated according to the appropriate regression coefficient (for each sugar at the concentration in the range of 10–200 μg/mL).
After the disappearance of sugars (sucrose, monosaccharides), yeasts were deactivated by heating for 10 min at 95 °C. Then, the solution was cooled, filtered through qualitative filter paper, centrifuged (3500× g, at 4 °C, 20 min), and concentrated to 25 mL under vacuum. The purification and fractionation of cyclitols were performed using ion exchange resins: firstly, the solution was loaded on a cation exchange resin column (length of 50 cm, ø 2.5 cm) packed with DOWEX 50Wx8 (200–400 mesh, Sigma Aldrich, Saint Louis, MO, USA). The eluate was concentrated and cyclitols were separated on an anion-exchange resin column (DOWEX 1x8, 200–400 mesh, Sigma Aldrich, Saint Louis, MO, USA), using double-distilled degassed water. Fractions containing mainly d-pinitol were combined, concentrated to 20 mL and d-pinitol was decanted with absolute ethanol (99.9%) at 4 °C for 24 h. The white precipitate was oven evaporated at 40 °C to dryness. The dry powder contained mainly d-pinitol, a several-fold lower amount of myo-inositol, and traces of d-chiro-inositol (Supplementary Material, Figures S3 and S4).

3.2.2. GC-FID and GC-MS Analyses of d-pinitol

d-Pinitol purified from carob molasses as well as standard (from Sigma) was dissolved in water (10 mg/mL). Next, 5 μL of each was transferred into glass chromatographic vials and concentrated in a speed vacuum evaporator to dryness. Dry residues of both, pinitols and soluble carbohydrates (derived from fermented carob molasses—Section 3.2.1.) were derivatized with a mixture of 1-(trimethylsilyl)imidazole (TMSI) and pyridine (1:1, v/v). TMS-derivatives of cyclitols and soluble carbohydrates were analyzed by GC-FID method on a gas chromatograph GC2010Plus (Shimadzu, Kyoto, Japan) with a capillary column ZEBRON ZB-1 (15 m length, 0.25 mm diameter, and 0.1 μm film thickness, Phenomenex, USA). The injector temperature was 325 °C and the initial column oven temperature was 150 °C. Helium was used as carrier gas (at a flow rate of 1.18 mL/min). After the sample injection (1 μL, in a split ratio 10:1), the oven temperature (150 °C) was ramped to 200 °C at a rate of 20 °C/min, to 300 °C at 30 °C/min and to 335 °C at 20 °C/min. The final temperature was held for 10.42 min and the total time of analysis was 18 min. The detector was maintained at 350 °C.
GC-MS analysis was performed to compare the mass spectra of d-pinitol obtained from carob with those of the original standard. The GC-MS analytical method has been previously described in detail [56]. Briefly, the dry residues were derivatized in two steps. Firstly, 40 μL of O-metoxyamine hydrochloride (20 mg in 1 mL of pyridine) was added and samples were heated at 37 °C for 75 min (with continuous shaking at 500 rpm). Then, 160 μL of the mixture of N-methyl-N-(trimethylsilyl) trifluoroacetamide with pyridine (1:1, v/v) was added and heated at 70 °C for 30 min (according to the method described by Lisec et al. [57]. The TMS-derivatives of cyclitols were analyzed using GC-2010 coupled with a quadrupole mass spectrometry (MS) analyzer (GCMS-QP2010 Plus, Shimadzu, Kyoto, Japan), identified by comparison of the retention time and mass spectra of original standards (derived from Sigma-Aldrich, USA) and from the NIST 05 library (National Institute of Standards).

3.3. The CUPRAC Method Applied to Study the Ox-Red Activity of Cyclitols and Their Mixtures with Flavanones

Aqueous solutions of cyclitols with a starting concentration of 100 mg/mL and methanolic solutions of flavonoids with a starting concentration of 1 mg/mL were prepared. Solutions of copper(II) chloride (0.01 M Cu2+) in water, neocuproine (7.5 mM) in ethanol, and ammonium acetate (1 M) in water were prepared. Absorbance measurements of copper(II) and neocuproine solutions, after addition of the cyclitols under study, followed by cyclitols in a mixture with flavonoids and separately flavonoids alone, were carried out at a light wavelength of λ = 450 nm using a Unicam SP 1700 spectrophotometer. All measurements were performed in triplicate.

3.4. Spectrophotometrically DPPH-UV Radical Scavenging Assay

A total volume of 100 μL aliquot of each standard of cyclitols, flavonoids, or glutathione or a mixture of these compounds (at different concentrations, depending on the compound) was mixed with 350 μL of 200 μM DPPH in methanol and brought with methanol to a final volume of 1.0 mL. After 30 min, absorbance was measured at λ = 517 nm against a blank, containing all reagents except the tested samples. Assays were performed in triplicate. Under the described conditions, it was not possible to carry out tests with myo-inositol, l-chiro-inositol, and d-chiro-inositol because they precipitated out of the solutions during the reaction due to their very low solubility in methanol.

3.5. DPPH-UHPLC-UV Radical Scavenging Assay

The antioxidant activity was assessed with a UHPLC-UV analysis. Before the DPPH –UHPLC-UV analysis, the samples were prepared in the same way as described above. After the reaction, the samples were injected for UHPLC-UV analysis. The UHPLC system (Merck Hitachi, Germany) consisted of a pump (Model L-2160U), UV detector (Model L-2400U), autosampler (Model L-2200), a temperature-controlled column compartment (Model L-2350U), and a degasser module. The EZ Chrom Elite System Manager was used for data acquisition and analysis.
Chromatographic analysis was conducted according to the following procedure—column: Synergi C18 Fusion-RP (50 × 2.0 mm, 4 μm, Phenomenex), mobile phase: (A) 0.05% TFA in water and (B) acetonitrile (linear gradient from 30% B to 80% B in 2 min; then changed to 30% B immediately and held at 30% B for 2 min to equilibrate the column); temperature: 25 °C, injection volume 2 μL, detection UV λ = 517 nm (monitored DPPH˙ peak). The retention time Tr of the DPPH signal was 2.15 min [53].

4. Conclusions

Extensive, completely novel studies of the antioxidant properties of a wide spectrum of compounds—cyclitols, flavanones, and glutathione, separately and their mixtures (in different concentration ranges), by the CUPRAC, DPPH-radical, and DPPH-UHPLC-UV methods revealed very weak antioxidant activity of cyclitols, comparing with those of flavanones and glutathione. The major novelty of the present studies is the discovery of synergy between glutathione by methyl-ether derivatives of cyclitols (d-pinitol and l-quebrachitol), leading to significant enhancement of the antioxidative properties of their mixtures. It can be expected that this information will serve clinicians to study how the amount of glutathione produced by the body or its supplementation affects the efficacy of cyclitols as drugs in several diseases. Moreover, a weaker synergism between glutathione and some flavanones enables us to the suggestion that mixtures of glutathione, cyclitols, and some flavanones could increase their antioxidative properties/therapeutic effects.

Supplementary Materials

The following are available online. Figure S1: Chemical structure of analyzed cyclitols and methylated derivatives (l-quebrachitol and d-pinitol). Figure S2. Changes in absorbance of l-quebrachitol, flavanones, and glutathione and mixtures of l-quebrachitol with flavanones and glutathione. Figure S3: The GC-FID chromatograms of TMS-derivatives of d-pinitol: from Sigma (A) and isolated from carob (B). Abbreviations: 1—internal standard (xylitol), 2—d-pinitol; 3—d-chiro-inositol, 4—myo-inositol. Figure S4a: The comparison of mass spectra of d-pinitol purified from carob (A, compound no 2 on Figure S3B) with original standard (B) and d-pinitol from NIST Library (C). Figure S4b. The comparison of mass spectra of d-chiro-inositol (A, compound no 3 on Figure S3B), found as an impurity of d-pinitol isolated from carob, with mass spectra of original standard of d-chiro-inositol (B) and d-chiro-inositol from NIST Library (C). Figure S4c: The comparison of mass spectra of myo-inositol (A, compound no 4 on Figure S3B), found as impurity of d-pinitol isolated from carob, with mass spectra of original standard of myo-inositol (B) and myo-inositol from NIST Library (C).

Author Contributions

L.B.L.—research idea, writing the manuscript; L.B.L., J.S.-P.—isolation, purification and GC-MS analyses of d-pinitol from carob; J.P.—HPLC analyses, spectrophotometric analyses; I.B.—research planning, interpretation of results, writing the manuscript; B.B.—scientific supervision and revision of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported from the project “Advanced Biocomposites for Tomorrow’s Economy BIOG-NET”, FNP POIR.04.04.00-00-1792/18-00, project is carried out within the TEAMNET programme funded by the Foundation for Polish Science and co-financed by the European Union under the European Regional Development Fund.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of d-pinitol purified from carob are available from the authors.

Abbreviations

CUPRACCupric Ion Reducing Antioxidant Capacity
DPPH2,2-diphenyl-1-picrylhydrazyl radical
UHPLC-UVultra-high performance liquid chromatography with ultraviolet detection
RSAradical scavenging activity
IC5050% inhibition of the radical scavenging effect
GC-FIDhigh-resolution gas chromatography with flame ionization detection
GC-MSgas chromatography with mass spectrometry detection

References

  1. Michell, R.H. Evolution of the diverse biological role of inositols. Biochem. Soc. Symp. 2007, 74, 223–246. [Google Scholar] [CrossRef] [Green Version]
  2. Obendorf, R.L.; Górecki, R.J. Soluble carbohydrates in legume seeds. Seed Sci. Res. 2012, 22, 219–242. [Google Scholar] [CrossRef]
  3. Poongothai, G.; Sripathi, S.K. A review on insulinomimetic pinitol from plants. Int. J. Pharm. Bio. Scis. 2013, 4, 992–1009. [Google Scholar]
  4. Al-Suod, H.; Ligor, M.; Ratiu, I.-A.; Rafińska, K.; Górecki, R.; Buszewski, B. A window on cyclitols: Characterization and analytics of inositols. Phytochem. Lett. 2017, 20, 507–519. [Google Scholar] [CrossRef]
  5. Gridland, C.; Gillaspy, G. Inositol pyrophosphate pathways and mechanisms: What can we learn from plants? Molecules 2020, 25, 2789. [Google Scholar] [CrossRef]
  6. Lee, S.; Kim, M.-G.; Ahn, H.; Kim, S. Inositol pyrophosphates: Signaling molecules with pleiotropic actions in mammals. Molecules 2020, 25, 2208. [Google Scholar] [CrossRef]
  7. Loewus, F.A.; Murthy, P.P.N. myo-Inositol metabolism in plants. Plant Sci. 2000, 150, 1–19. [Google Scholar] [CrossRef]
  8. Valluru, R.; Van den Ende, W. Myo-inositol and beyond—Emerging networks under stress. Plant Sci. 2011, 181, 387–400. [Google Scholar] [CrossRef]
  9. Merchant, A.; Richter, A. Polyols as biomarkers and bioindicators for 21 century plant breeding. Funct. Plant Biol. 2011, 38, 934–940. [Google Scholar] [CrossRef] [Green Version]
  10. Yancey, P.H. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J. Exp. Biol. 2005, 208, 2819–2830. [Google Scholar] [CrossRef] [Green Version]
  11. Ortbauer, M.; Popp, M. Functional role of polyhydroxy compounds on protein structure and thermal stability studied by circular dichroism spectroscopy. Plant Physiol. Biochem. 2008, 46, 428–434. [Google Scholar] [CrossRef]
  12. Owczarczyk-Saczonek, A.; Lahuta, L.B.; Ligor, M.; Placek, W.; Górecki, R.J.; Buszewski, B. The healing-promoting properties of selected cyclitols—A review. Nutrients 2018, 10, 1891. [Google Scholar] [CrossRef] [Green Version]
  13. Antonowski, T.; Osowski, A.; Lahuta, L.; Górecki, R.; Rynkiewicz, A.; Wojtkiewicz, J. Health-promoting properties of selected cyclitols for metabolic syndrome and diabetes. Nutrients 2019, 11, 2314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Chhetri, D.R. Myo-Inositol and its derivatives: Their emerging role in the treatment of huma diseases. Front. Pharmacol. 2019, 10, 1172–1180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Kiani, A.K.; Paolacci, S.; Galogero, A.E.; Cannarella, R.; Di Renzo, G.C.; Gerli, S.; Della Morte, C.; Busetto, G.M.; De Berardinis, E.; Del Giudice, F.; et al. From Myo-inositol to D-chiro-inositol molecular pathways. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 2390–2402. [Google Scholar]
  16. Davinelli, S.; Nicolosi, D.; Di Cesare, C.; Scapagnini, G.; Di Marco, R. Targeting metabolic consequences of insulin re-sistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: A focused review. J. Clin. Med. 2020, 9, 987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Facchinetti, F.; Appetecchia, M.; Aragona, C.; Bevilacqua, A.; Bezerra Espinola, M.S.; Bizzarri, M.; D’Anna, R.; Dewailly, D.; Diamanti-Kandarakis, E.; Hernández Marín, I.; et al. Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: A further help for human reproduction and beyond. Expert Opin. Drug Metab. Toxicol. 2020, 16, 255–274. [Google Scholar] [CrossRef] [PubMed]
  18. López-Gambero, A.J.; Sanjuan, C.; Serrano-Castro, P.J.; Suárez, J.; de Fonseca, F.R. The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases. Biomedicines 2020, 8, 295. [Google Scholar] [CrossRef] [PubMed]
  19. Frej, A.D.; Otto, G.P.; Williams, R.S.B. Tipping the scales: Lessons from simple model systems on inositol imbalance in neurological disorders. Eur. J. Cell Biol. 2017, 96, 154–163. [Google Scholar] [CrossRef] [PubMed]
  20. Srivastava, K.; Tiwari, M.; Dubey, A.; Dwivedi, A. D-Pinitol–a natural phytomolecule and its pharmacological effect. IJPLS 2020, 11, 6609–6623. [Google Scholar]
  21. López-Sánchez, J.I.; Moreno, D.A.; García-Viguera, C. D-pinitol, a highly valuable product from carob pods: Health-promoting effects and metabolic pathways of this natural super-food ingredient and its derivatives. AIMS Agric. Food 2018, 3, 41–63. [Google Scholar] [CrossRef]
  22. Sánchez-Hidalgo, M.; León-González, A.J.; Gálvez-Peralta, M.; González-Mauraza, N.H.; Martin-Cordero, C. D-Pinitol: A cyclitol with versatile biological and pharmacological activities. Phytochem. Rev. 2021, 20, 211–224. [Google Scholar] [CrossRef]
  23. Wang, D.; Zhang, S.; Chang, Z.; Kong, D.-X.; Zuo, Z. Quebrachitol: Global status and basic research. Nat. Prod. Bioprospect. 2017, 7, 113–122. [Google Scholar] [CrossRef] [Green Version]
  24. Yodthong, T.; Kedjarune-Leggat, U.; Smythe, C.; Wititsuwannakul, R.; Pitakpornpreecha, T. L-Quebrachitol promotes the proliferation, differentiation, and mineralization of MC3T3-E1 cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/b-catenin signaling pathway. Molecules 2018, 23, 3086. [Google Scholar] [CrossRef] [Green Version]
  25. Formoso, G.; Baldassarre, M.P.A.; Ginestra, F.; Carlucci, M.A.; Bucci, I.; Consoli, A. Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. Diabetes Metab. Res. Rev. 2019, 35, e3154. [Google Scholar] [CrossRef]
  26. Orthen, B.; Popp, M.; Smirnoff, N. Hydroxyl radical scavenging properties of cyclitols. Proc. R. Soc. Edinb. Sect. B Biol. Sci. 1994, 102, 269–272. [Google Scholar] [CrossRef]
  27. Rengarajan, T.; Rajendran, P.; Nandakumar, N.; Balasubramanian, M.P.; Nishigaki, I. Free radical scavenging and antioxidant activity of D-pinitol against 7, 12 dimethylbenz (a) anthracene induced breast cancer in sprague dawley rats. Asian Pac. J. Trop. Dis. 2014, 4, 384–390. [Google Scholar] [CrossRef]
  28. Lemos, T.L.G.; Machado, L.L.; Souza, J.S.N.; Fonseca, A.M.; Maia, J.L.; Pessoa, O.D.L. Antioxidant, ichtyotoxicity and brine shrimp lethality tests of Magnolia glabrata. Fitoterapia 2006, 77, 443–445. [Google Scholar] [CrossRef]
  29. Mo, E.J.; Ahn, J.H.; Jo, Y.H.; Kim, S.B.; Hwang, B.Y.; Lee, M.K. Inositol derivatives and phenolic compounds from the roots of Taraxacum coreanum. Molecules 2017, 22, 1349. [Google Scholar] [CrossRef] [Green Version]
  30. Tewari, R.; Gupta, M.; Ahmad, F.; Rout, P.K.; Misra, L.; Patwardhan, A.; Vasudeva, R. Extraction, quantification and antioxidant activities of flavonoids, polyphenols and pinitol from wild and cultivated Saraca asoca bark using RP-HPLC-PDA-RI method. Ind. Crops Prod. 2017, 103, 73–80. [Google Scholar] [CrossRef]
  31. Khan, J.; Deb, P.K.; Priya, S.; Medina, K.D.; Devi, R.; Walode, S.G.; Rudrapal, M. Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules 2021, 26, 4021. [Google Scholar] [CrossRef]
  32. Hasanuzzaman, M.; Nahar, K.; Anee, T.I.; Fujita, M. Glutathione in plants: Biosynthesis and physiological role in environmental stress tolerance. Physiol. Mol. Biol. Plants 2017, 23, 249–268. [Google Scholar] [CrossRef]
  33. Zechmann, B. Subcellular roles of glutathione in mediating plant defense during biotic stress. Plants 2020, 9, 1067. [Google Scholar] [CrossRef]
  34. Marí, M.; de Gregorio, E.; de Dios, C.; Roca-Agujetas, V.; Cucarull, B.; Tutusaus, A.; Morales, A.; Colell, A. Mitochondrial glutathione: Recent insights and role in disease. Antioxidants 2020, 9, 909. [Google Scholar] [CrossRef]
  35. Sikora, E.; Cieślik, E.; Topolska, K. The sources of natural antioxidants. Acta Sci. Pol. Technol. Aliment. 2008, 7, 5–17. [Google Scholar]
  36. Xu, D.-P.; Li, Y.; Meng, X.; Zhou, T.; Zhou, Y.; Zheng, J.; Zhang, J.-J.; Li, H.-B. Natural antioxidants in foods and medicinal plants: Extraction, assessment, and resources. Int. J. Mol. Sci. 2017, 18, 96. [Google Scholar] [CrossRef]
  37. Lourenço, S.C.; Moldão-Martins, M.; Alves, V.D. Antioxidants of natural plant origins: From sources to food industry applications. Molecules 2019, 24, 4132. [Google Scholar] [CrossRef] [Green Version]
  38. Robards, K.; Prenzler, P.D.; Tucker, G.; Swatsitang, P.; Glovera, W. Phenolic compounds and their role in oxidative processes in fruits. Food Chem. 1999, 66, 401–436. [Google Scholar] [CrossRef]
  39. Cook, N.C.; Samman, S. Flavonoids—Chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996, 7, 66–77. [Google Scholar] [CrossRef]
  40. Rains, J.; Jain, S.K. Oxidative stress, insulin signaling and diabetes. Free Radic. Biol. Med. 2011, 50, 567–575. [Google Scholar] [CrossRef] [Green Version]
  41. Lassere, A.M.; Marti–Soler, H.; Strippoli, M.P.; Vaucher, J.; Glaus, J.; Vandeleur, C.L.; Castelao, E.; Marques-Vidal, P.; Waeber, G.; Vollenweider, P.; et al. Clinical and course characteristic of depression and all—Cause mortality. A prospective population based study. J. Affect Disord. 2016, 189, 17–24. [Google Scholar] [CrossRef] [Green Version]
  42. Saki, K.; Bahmani, M.; Rafieian–Kopaei, M. The effect of most important medicinal plants on two important psychiatric disorders (anxiety and depression)—A review. Asian Pac. J. Trop. Med. 2014, 7, 534–542. [Google Scholar] [CrossRef] [Green Version]
  43. Nones, J.; de Sampaio e Spohr, T.C.L.; Gomes, F.C.A. Hesperidin, a flavone glycoside, as mediator of neuronal survival. Neurochem. Res. 2011, 36, 1776–1784. [Google Scholar] [CrossRef]
  44. Baranowska, I.; Bajkacz, S. A new HPLC-MS/MS method for the determination of flavonoids in supplements and DPPH-UHPLC-UV method for the evaluation the radical scavenging activity of flavonoids. Food Chem. 2018, 256, 333–341. [Google Scholar] [CrossRef]
  45. Cho, J. Antioxidant and neuroprotective effects of hesperitin and its aglycone hesperetin. Arch. Pharm. Res. 2006, 29, 699–706. [Google Scholar] [CrossRef]
  46. Gu, S.-F.; Wang, L.-Y.; Tian, Y.-J.; Zhou, Z.-X.; Tang, J.-B.; Liu, X.-R.; Jiang, H.-P.; Shen, Y.-Q. Enhanced water solubility antioxidant activity and oral absorption of hesperetin by D-α-tocoferyl polyethylene glycol 1000 succinate and phosphatidyl-choline. J. Zhejiang Univ. Sci. B 2019, 20, 273–281. [Google Scholar] [CrossRef]
  47. Liu, Y.; Xie, S.; Wang, Y.; Luo, K.; Wang, Y.; Cai, Y. Liguiritigenin inhibits tumor growth and vascularization in a mouse model Hela cells. Molecules 2012, 17, 7206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Yanez, J.A.; Remsberg, C.M.; Miranda, N.D.; Vega-Villa, K.R.; Andrews, P.K.; Davies, N.M. Pharmacokinetics of selected chiral flavonoids: Hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharm. Drug Dispos. 2008, 29, 63–82. [Google Scholar] [CrossRef]
  49. Erlund, J. Review of flavonoids quercetin, hesperetin and naringenin. Dietary sources, bioactivities, bioavailability and epidemiology. Nutr. Res. 2004, 24, 851–874. [Google Scholar] [CrossRef]
  50. Asatsuma-Okumura, T.; Ito, T.; Handa, H. Molecular mechanisms of the teratogenic effects of thalidomide. Pharmaceuticals 2020, 13, 95. [Google Scholar] [CrossRef]
  51. Valencia, E.; Martin, A.; Hardy, G. Glutathione—Nutritional and pharmacologic viewpoints. Part II. Nutrition 2001, 17, 696–697. [Google Scholar] [CrossRef]
  52. Pereira, R.B.; Sousa, C.; Costa, A.; Andrade, P.B.; Valentao, P. Glutathione and the antioxidant potential of binary mixtures with flavonoids: Synergism and antagonism. Molecules 2013, 18, 8858. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Magiera, S.; Baranowska, I.; Lautenszleger, A. UHPLC–UV method for the determination of flavonoids in dietary supplements and for evaluation of their antioxidant activities. J. Pharm. Biomed. Anal. 2015, 102, 468–475. [Google Scholar] [CrossRef]
  54. Ruiz-Aceituno, L.; Rodríguez-Sánchez, S.; Ruiz-Matute, A.I.; Ramos, L.; Soria, A.C.; Sanz, M.L. Optimisation of a biotechnological procedure for selective fractionation of bioactive inositols in edible legume extracts. J. Sci. Food Agric. 2013, 93, 2797–2803. [Google Scholar] [CrossRef]
  55. Lahuta, L.B. Biosynthesis of raffinose family oligosaccharides and galactosyl pinitols in developing and maturing seeds of winter vetch (Vicia villosa Roth.). Acta Soc. Bot. Pol. 2006, 75, 219–227. [Google Scholar] [CrossRef] [Green Version]
  56. Szablińska-Piernik, J.; Lahuta, L.B. Metabolite profiling of semi-leafless pea (Pisum sativum L.) under progressive soil drought and subsequent re-watering. J. Plant Physiol. 2021, 256, 153314–153324. [Google Scholar] [CrossRef] [PubMed]
  57. Lisec, J.; Schauer, N.; Kopka, J.; Willmitzer, L.; Fernie, A.R. Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat. Protoc. 2006, 1, 387–396. [Google Scholar] [CrossRef]
Molecules 27 00158 g001 550
Figure 1. Absorbance change graph of d-pinitol (standard), d-pinitol from carob, flavanones and their mixtures with cyclitols.
Figure 1. Absorbance change graph of d-pinitol (standard), d-pinitol from carob, flavanones and their mixtures with cyclitols.
Molecules 27 00158 g001
Molecules 27 00158 g002 550
Figure 2. Absorbance change graph of l-quebrachitol, myo-inositol, flavanones and their mixtures with cyclitols.
Figure 2. Absorbance change graph of l-quebrachitol, myo-inositol, flavanones and their mixtures with cyclitols.
Molecules 27 00158 g002
Molecules 27 00158 g003 550
Figure 3. Changes in absorbance of d-pinitol (standard 11.7 mg/mL), d-pinitol from carob (11.7 mg/mL), flavanones (hesperetin, naringenin 16.7 μg/mL; liquiritigenin 20 μg/mL; eriodictyol 6.7 μg/mL), and mixtures of flavanones with cyclitols.
Figure 3. Changes in absorbance of d-pinitol (standard 11.7 mg/mL), d-pinitol from carob (11.7 mg/mL), flavanones (hesperetin, naringenin 16.7 μg/mL; liquiritigenin 20 μg/mL; eriodictyol 6.7 μg/mL), and mixtures of flavanones with cyclitols.
Molecules 27 00158 g003
Molecules 27 00158 g004 550
Figure 4. Changes in absorbance of glutathione and its mixture with d-pinitol (standard) at different concentration levels.
Figure 4. Changes in absorbance of glutathione and its mixture with d-pinitol (standard) at different concentration levels.
Molecules 27 00158 g004
Molecules 27 00158 g005 550
Figure 5. Changes in absorbance of glutathione (16.7 μg/mL), flavanones (hesperetin, naringenin 16.7 μg/mL; eriodictyol 6.7 μg/mL; liquiritigenin 20 μg/mL) and mixtures of individual flavanones with glutathione.
Figure 5. Changes in absorbance of glutathione (16.7 μg/mL), flavanones (hesperetin, naringenin 16.7 μg/mL; eriodictyol 6.7 μg/mL; liquiritigenin 20 μg/mL) and mixtures of individual flavanones with glutathione.
Molecules 27 00158 g005
Molecules 27 00158 g006 550
Figure 6. Example of a chromatogram of the DPPH radical signal (black line), DPPH radical signal after reaction with d-pinitol from carob (blue line), and DPPH radical signal after reaction with a mixture of d-pinitol from carob and glutathione (red line).
Figure 6. Example of a chromatogram of the DPPH radical signal (black line), DPPH radical signal after reaction with d-pinitol from carob (blue line), and DPPH radical signal after reaction with a mixture of d-pinitol from carob and glutathione (red line).
Molecules 27 00158 g006
Table
Table 1. Antioxidant activity of mixtures of cyclitols with flavonoids and glutathione.
Table 1. Antioxidant activity of mixtures of cyclitols with flavonoids and glutathione.
CyclitolRSA%AntioxidantRSA%Theoretical RSA%Experimental RSA%Change of RSA%
d-Pinitol
(10 mg/mL)		19.3Hesperetin
(50 μg/mL)		43.662.936.4↓↓
Naringenin
(100 μg/mL)		25.845.121.2↓↓
Eriodictyol
(2 μg/mL)		41.961.237.0↓↓
Liquiritigenin
(20 μg/mL)		22.641.921.5↓↓
Glutathione
(10 μg/mL)		30.750.054.0↔
d-Pinitol from carob
(10 mg/mL)		6.6Hesperetin
(50 μg/mL)		43.650.237.9↓↓
Naringenin
(100 μg/mL)		25.832.416.9↓↓
Eriodictyol
(2 μg/mL)		41.948.534.9↓
Liquiritigenin
(20 μg/mL)		22.629.221.6↔
Glutathione
(10 μg/mL)		30.737.379.9↑↑
l-Quebrachitol
(10 mg/mL)		14.0Hesperetin
(50 μg/mL)		43.657.658.1↔
Naringenin
(100 μg/mL)		25.839.818.1↓↓
Eriodictyol
(2 μg/mL)		41.955.934.1↓↓
Liquiritigenin
(20 μg/mL)		22.636.620.5↓
Glutathione
(10 μg/mL)		30.744.742.7↔
l-chiro-Inositol
(10 mg/mL)		9.8Hesperetin
(50 μg/mL)		43.653.738.8↓
Naringenin
(100 μg/mL)		25.835.620.2↓
Eriodictyol
(2 μg/mL)		41.951.731.3↓↓
Liquiritigenin
(20 μg/mL)		22.632.416.2↓↓
Glutathione
(10 μg/mL)		30.740.553.9↑↑
d-chiro-Inositol
(10 mg/mL)		18.5Hesperetin
(50 μg/mL)		43.662.144.2↓
Naringenin
(100 μg/mL)		25.844.312.9↓↓
Eriodictyol
(2 μg/mL)		41.960.436.3↓↓
Liquiritigenin
(20 μg/mL)		22.641.122.2↓↓
Glutathione
(10 μg/mL)		30.749.275.6↑↑
myo-Inositol
(10 mg/mL)		16.5Hesperetin
(50 μg/mL)		43.660.142.1↓
Naringenin
(100 μg/mL)		25.842.324.3↓↓
Eriodictyol
(2 μg/mL)		41.958.425.8↓↓
Liquiritigenin
(20 μg/mL)		22.639.113.4↓↓
Glutathione
(10 μg/mL)		30.747.231.8↓
legend: ↓↓—strong reduction of the antioxidant activity of the mixture; ↓—weak decrease of the antioxidant activity of the mixture; ↑↑—strong increase in the antioxidant activity of the mixture; ↔—lack of change in antioxidant activity of the mixture.
Table
Table 2. The IC50 values for selected cyclitols, flavanones, and glutathione.
Table 2. The IC50 values for selected cyclitols, flavanones, and glutathione.
CompoundIC50Scavenging Activity
Myo-Inositol117.3 mg/mLvery weak
d-Pinitol14.3 mg/mLvery weak
Eriodictyol2.8 μg/mLvery strong
Hesperetin30.8 μg/mLstrong
Naringenin210.0 μg/mLweak
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Płonka, J.; Szablińska-Piernik, J.; Buszewski, B.; Baranowska, I.; Lahuta, L.B. Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione. Molecules 2022, 27, 158. https://doi.org/10.3390/molecules27010158

AMA Style

Płonka J, Szablińska-Piernik J, Buszewski B, Baranowska I, Lahuta LB. Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione. Molecules. 2022; 27(1):158. https://doi.org/10.3390/molecules27010158

Chicago/Turabian Style

Płonka, Joanna, Joanna Szablińska-Piernik, Bogusław Buszewski, Irena Baranowska, and Lesław B. Lahuta. 2022. "Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione" Molecules 27, no. 1: 158. https://doi.org/10.3390/molecules27010158

Article Metrics

Back to TopTop